Fox Chase Cancer Center Welcomes Dr. Sara Small

Dr. small
Fox Chase Cancer Center is pleased to announce the hiring of Sara Small, MD, PhD, as an assistant professor in the Department of Bone Marrow Transplant and Cellular Therapies.

PHILADELPHIA (September 12, 2023) — Fox Chase Cancer Center is pleased to announce the hiring of Sara Small, MD, PhD, as an assistant professor in the Department of Bone Marrow Transplant and Cellular Therapies.

Most recently, Small was a fellow in hematology/oncology in the Department of Medicine at Northwestern Memorial Hospital in Chicago, where she also completed a residency in internal medicine, receiving the Residency Excellence in Teaching Award.

She received her undergraduate degree from Columbia University. She earned a doctorate in cellular and molecular biology and a medical degree in 2017, both from the University of Pennsylvania School of Medicine’s Medical Scientist Training Program.

Small’s research seeks to understand how modulation of inflammatory signaling pathways can be leveraged to develop novel treatments that overcome chemotherapy resistance in leukemia. As a predoctoral fellow in Penn’s Cancer Biology Department, Small studied proteins secreted by cells in response to stress and how this contributes to cell senescence, cancer, and aging. Her work was recognized with an NIH Individual NRSA MD/PhD Fellowship granted by the National Institute on Aging.

Small has published numerous studies in peer-reviewed journals, including Science Signaling, Leukemia, and Leukemia & Lymphoma, where she is also a peer reviewer. She has presented her research at both national and international conferences.

She is also the recipient of the American Society of Hematology Research Training Award for Fellows grant and recently received the Hematology/Oncology Fellowship Teaching Award from Northwestern Memorial Hospital.

Small began her tenure at Fox Chase on August 21.

Fox Chase Cancer Center (Fox Chase), which includes the Institute for Cancer Research and the American Oncologic Hospital and is a part of Temple Health, is one of the leading comprehensive cancer centers in the United States. Founded in 1904 in Philadelphia as one of the nation’s first cancer hospitals, Fox Chase was also among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase is also one of just 10 members of the Alliance of Dedicated Cancer Centers. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are also routinely recognized in national rankings, and the Center’s nursing program has received the Magnet recognition for excellence six consecutive times. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship, and community outreach. It is the policy of Fox Chase Cancer Center that there shall be no exclusion from, or participation in, and no one denied the benefits of, the delivery of quality medical care on the basis of race, ethnicity, religion, sexual orientation, gender, gender identity/expression, disability, age, ancestry, color, national origin, physical ability, level of education, or source of payment.

For more information, call 888-369-2427